Back to Search Start Over

Beyond Air(r) declares that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis

Source :
European Union News. October 4, 2022
Publication Year :
2022

Abstract

GARDEN CITY, N.Y: Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
European Union News
Publication Type :
News
Accession number :
edsgcl.723811250